Literature DB >> 33332356

Characteristics and outcomes of COVID-19 patients in New York City's public hospital system.

Roopa Kalyanaraman Marcello1, Johanna Dolle1, Sheila Grami1, Richard Adule1, Zeyu Li1, Kathleen Tatem1, Chinyere Anyaogu2, Stephen Apfelroth3, Raji Ayinla4, Noella Boma5, Terence Brady6, Braulio F Cosme-Thormann7, Roseann Costarella8, Kenra Ford8, Kecia Gaither9, Jessica Jacobson10, Marc Kanter9, Stuart Kessler11, Ross B Kristal12, Joseph J Lieber11, Vikramjit Mukherjee10, Vincent Rizzo13, Madden Rowell12, David Stevens14, Elana Sydney3, Andrew Wallach12, Dave A Chokshi1, Nichola Davis1.   

Abstract

BACKGROUND: New York City (NYC) bore the greatest burden of COVID-19 in the United States early in the pandemic. In this case series, we describe characteristics and outcomes of racially and ethnically diverse patients tested for and hospitalized with COVID-19 in New York City's public hospital system.
METHODS: We reviewed the electronic health records of all patients who received a SARS-CoV-2 test between March 5 and April 9, 2020, with follow up through April 16, 2020. The primary outcomes were a positive test, hospitalization, and death. Demographics and comorbidities were also assessed.
RESULTS: 22254 patients were tested for SARS-CoV-2. 13442 (61%) were positive; among those, the median age was 52.7 years (interquartile range [IQR] 39.5-64.5), 7481 (56%) were male, 3518 (26%) were Black, and 4593 (34%) were Hispanic. Nearly half (4669, 46%) had at least one chronic disease (27% diabetes, 30% hypertension, and 21% cardiovascular disease). Of those testing positive, 6248 (46%) were hospitalized. The median age was 61.6 years (IQR 49.7-72.9); 3851 (62%) were male, 1950 (31%) were Black, and 2102 (34%) were Hispanic. More than half (3269, 53%) had at least one chronic disease (33% diabetes, 37% hypertension, 24% cardiovascular disease, 11% chronic kidney disease). 1724 (28%) hospitalized patients died. The median age was 71.0 years (IQR 60.0, 80.9); 1087 (63%) were male, 506 (29%) were Black, and 528 (31%) were Hispanic. Chronic diseases were common (35% diabetes, 37% hypertension, 28% cardiovascular disease, 15% chronic kidney disease). Male sex, older age, diabetes, cardiac history, and chronic kidney disease were significantly associated with testing positive, hospitalization, and death. Racial/ethnic disparities were observed across all outcomes. CONCLUSIONS AND RELEVANCE: This is the largest and most racially/ethnically diverse case series of patients tested and hospitalized for COVID-19 in New York City to date. Our findings highlight disparities in outcomes that can inform prevention and testing recommendations.

Entities:  

Year:  2020        PMID: 33332356     DOI: 10.1371/journal.pone.0243027

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  28 in total

1.  Disaggregating Asian Race Reveals COVID-19 Disparities Among Asian American Patients at New York City's Public Hospital System.

Authors:  Roopa Kalyanaraman Marcello; Johanna Dolle; Areeba Tariq; Sharanjit Kaur; Linda Wong; Joan Curcio; Rosy Thachil; Stella S Yi; Nadia Islam
Journal:  Public Health Rep       Date:  2021-12-30       Impact factor: 2.792

2.  Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression.

Authors:  Romil Singh; Sawai Singh Rathore; Hira Khan; Smruti Karale; Yogesh Chawla; Kinza Iqbal; Abhishek Bhurwal; Aysun Tekin; Nirpeksh Jain; Ishita Mehra; Sohini Anand; Sanjana Reddy; Nikhil Sharma; Guneet Singh Sidhu; Anastasios Panagopoulos; Vishwanath Pattan; Rahul Kashyap; Vikas Bansal
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-03       Impact factor: 6.055

3.  Characterization of test positivity among patients with coronavirus disease 2019 (COVID-19) in three electronic health records databases, February-November 2020.

Authors:  Patrick Saunders-Hastings; Cindy Ke Zhou; Shayan Hobbi; Hui-Lee Wong; Patricia Lloyd; Eva Boyd; Nader Alawar; Tainya C Clarke; Jeff Beers; Timothy Burrell; Azadeh Shoaibi
Journal:  BMC Public Health       Date:  2022-06-18       Impact factor: 4.135

4.  Correlation of Coagulation Parameters With Clinical Outcomes During the Coronavirus-19 Surge in New York: Observational Cohort.

Authors:  Morayma Reyes Gil; Jesus D Gonzalez-Lugo; Shafia Rahman; Mohammad Barouqa; James Szymanski; Kenji Ikemura; Yungtai Lo; Henny H Billett
Journal:  Front Physiol       Date:  2021-02-23       Impact factor: 4.566

5.  COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis.

Authors:  Firoozeh V Gerayeli; Stephen Milne; Chung Cheung; Xuan Li; Cheng Wei Tony Yang; Anthony Tam; Lauren H Choi; Annie Bae; Don D Sin
Journal:  EClinicalMedicine       Date:  2021-03-18

6.  Hospitalization and mortality associated with SARS-CoV-2 viral clades in COVID-19.

Authors:  Kenji Nakamichi; Jolie Z Shen; Cecilia S Lee; Aaron Lee; Emma A Roberts; Paul D Simonson; Pavitra Roychoudhury; Jessica Andriesen; April K Randhawa; Patrick C Mathias; Alex L Greninger; Keith R Jerome; Russell N Van Gelder
Journal:  Sci Rep       Date:  2021-02-26       Impact factor: 4.996

7.  Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis.

Authors:  Shirley Sze; Daniel Pan; Clareece R Nevill; Laura J Gray; Christopher A Martin; Joshua Nazareth; Jatinder S Minhas; Pip Divall; Kamlesh Khunti; Keith R Abrams; Laura B Nellums; Manish Pareek
Journal:  EClinicalMedicine       Date:  2020-11-12

8.  Pacific Islanders in the Era of COVID-19: an Overlooked Community in Need.

Authors:  Leah Cha; Thomas Le; Taunuu Ve'e; Natalie T Ah Soon; Winston Tseng
Journal:  J Racial Ethn Health Disparities       Date:  2021-06-24

Review 9.  Asthma and COVID-19: a dangerous liaison?

Authors:  Carlo Lombardi; Federica Gani; Alvise Berti; Pasquale Comberiati; Diego Peroni; Marcello Cottini
Journal:  Asthma Res Pract       Date:  2021-07-15

Review 10.  Severe acute respiratory syndrome coronavirus-2: implications for blood safety and sufficiency.

Authors:  Philip Kiely; Veronica C Hoad; Clive R Seed; Iain B Gosbell
Journal:  Vox Sang       Date:  2020-09-23       Impact factor: 2.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.